Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Communication, Coordination, and Security for People with Multiple Sclerosis (COCOS-MS): a randomised phase II clinical trial protocol.
Golla H, Dillen K, Hellmich M, Dojan T, Ungeheuer S, Schmalz P, Staß A, Mildenberger V, Goereci Y, Dunkl V, Strupp J, Fink GR, Voltz R, Stock S, Cornely O, Stahmann A, Müller A, Löcherbach P, Burghaus L, Limmroth V, Bonmann E, Gerbershagen K, Nelles G, Joist T, Haas J, Temmes H, Warnke C. Golla H, et al. Among authors: mildenberger v. BMJ Open. 2022 Jan 25;12(1):e049300. doi: 10.1136/bmjopen-2021-049300. BMJ Open. 2022. PMID: 35078833 Free PMC article.
Cm-p5 Peptide Dimers Inhibit Biofilms of Candida albicans Clinical Isolates, C. parapsilosis and Fluconazole-Resistant Mutants of C. auris.
Amann V, Kissmann AK, Mildenberger V, Krebs I, Perez-Erviti JA, Martell-Huguet EM, Otero-Gonzalez AJ, Morales-Vicente F, Rodríguez-Castaño GP, Firacative C, Rodríguez A, Ständker L, Weil T, Spellerberg B, Stenger S, Rosenau F. Amann V, et al. Among authors: mildenberger v. Int J Mol Sci. 2023 Jun 6;24(12):9788. doi: 10.3390/ijms24129788. Int J Mol Sci. 2023. PMID: 37372935 Free PMC article.
Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial.
Kautz-Freimuth S, Redaèlli M, Shukri A, Kentenich H, Simic D, Mildenberger V, Schmutzler R, Rhiem K, Stock S. Kautz-Freimuth S, et al. Among authors: mildenberger v. BMC Med Inform Decis Mak. 2023 Oct 16;23(1):223. doi: 10.1186/s12911-023-02327-9. BMC Med Inform Decis Mak. 2023. PMID: 37845719 Free PMC article. Clinical Trial.
The Designed Pore-Forming Antimicrobial Peptide C14R Combines Excellent Activity against the Major Opportunistic Human Pathogen Pseudomonas aeruginosa with Low Cytotoxicity.
Mildenberger V, Alpízar-Pedraza D, Martell-Huguet EM, Krämer M, Bolotnikov G, Otero-Gonzalez AJ, Weil T, Rodriguez-Alfonso A, Preising N, Ständker L, Vogel V, Spellerberg B, Kissmann AK, Rosenau F. Mildenberger V, et al. Pharmaceuticals (Basel). 2024 Jan 9;17(1):83. doi: 10.3390/ph17010083. Pharmaceuticals (Basel). 2024. PMID: 38256916 Free PMC article.